AlphAIAlphAI — Financial news for AI agents
gurufocus.comOCT 83 min read$TLRY

Tilray Brands (TLRY) Shares Slip Premarket After Q1 Revenue Miss

Tilray Brands (TLRY) reported Q1 revenue of $257.2M, up 23% YoY but below estimates by $9.7M. Cannabis revenue declined 13%, while beverage and distribution segments grew. The company posted a net loss of $3.0M but beat adjusted EPS estimates by $0.16. Tilray's P/S ratio is 0.45, below historical and industry averages, reflecting market skepticism about future growth.

Original reporting
gurufocus.com
Published Oct 8, 2026, 12:56 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 8, 2026, 1:36 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$TLRY
Bearish
medium confidence
Mentioned
$TLRY
Relevance
7/10
AlphAI data visualization · based on gurufocus.com
Decision brief

The 30-second read

$TLRYBearishMed
01

Why it matters

Revenue miss drives immediate price decline, but the low P/S ratio and EPS beat suggest potential upside for contrarian investors.

02

Market read

First‑report earnings release for a micro‑cap cannabis firm; provides fresh data for short‑term traders.

03

What to watch

Strong beverage and distribution performance may offset cannabis weakness in the longer term.

Relevance 7/10Novelty 8/10Timing: pre‑market today

Background

Tilray Brands reported fiscal Q1 results with mixed performance across its segments.

Company-level read

Ticker impact

$TLRYBearishMedium confidence
Context

Q1 revenue missed expectations while adjusted EPS beat estimates, causing pre‑market share decline.

Expected impact

downward pressure as investors weigh the revenue miss against the EPS beat

Evidence & confidence

Revenue miss signals slower top‑line growth; EPS beat may not offset concerns, leading to modest sell‑off.

Market effects

Sector

Cannabis and related consumer segments may see broader scrutiny after TLRY's miss.

Regional

North American cannabis stocks could face short‑term pressure.

Global

Limited to investors tracking cannabis and specialty beverage distributors.

Counterpoint

What could challenge this read

The EPS beat and low valuation multiples could attract value‑oriented buyers despite the revenue miss.

Key entities

  • company
    Tilray Brands Inc

    Canadian cannabis and beverage company reporting Q1 results.

Read at source← All news

Also covered by

3 outlets

Related articles

OCT 8
$TLRYMed

Tilray Brands Delivers Record Q1 Fiscal 2027 Revenue and Record Q1 Gross Profit, Demonstrating the Power of Its Global Platform, Driven by Double-Digit…

Tilray Brands, Inc. (TLRY) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 Tilray Brands Delivers Record Q1 Fiscal 2027 Revenue and Record Q1 Gross Profit, Demonstrating the Power of Its Global Platform, Driven by Double-Digit Year-Over-Year Growth Across International Cannabis, Beverage and Pharmaceutical Distribution First-Quarter Results

SEC EDGAR 8-K2 min
AUG 24
$CURLFHighAI 9/10

Curaleaf's Hostile Takeover Bid for Aurora Is Just the Tip of the Iceberg for Cannabis Consolidation. These 2 Stocks Could Be the Biggest Winners.

Curaleaf has made an unsolicited bid for Aurora Cannabis, offering a 45% premium. Aurora has not accepted the deal. Tilray Brands and Canopy Growth are also engaging in consolidation. Aurora recently acquired Safari Flower, while Canopy bought MTL Cannabis. Tilray is diversifying into alcohol and CBD. Investors should consider risks of consolidation strategies.

aol.com3 min